Literature DB >> 22565344

Treatment of persistent Mongolian spots with Q-switched alexandrite laser.

Shinji Kagami1, Akihiko Asahina, Yuta Uwajima, Akie Miyamoto, Daisuke Yamada, Sayaka Shibata, Mizuho Yamamoto, Yuri Masui, Shinichi Sato.   

Abstract

Mongolian spots are congenital and confluent hyperpigmented areas that are usually grayish blue in color. They are found most frequently in the sacral region in infants and typically disappear during childhood. Occasionally, they persist to adulthood. We retrospectively examined outcomes of laser treatment of persistent Mongolian spots. We used Q-switched alexandrite laser to treat persistent Mongolian spots of 16 Japanese patients at 14 years old or older. A good therapeutic outcome was achieved overall; however, postinflammatory hyperpigmentation and hypopigmentation were observed in two patients, respectively. While laser treatment was effective for all seven patients with extrasacral Mongolian spots, four out of ten patients with sacral Mongolian spots were refractory to treatment. Of these patients, two received laser irradiation only twice and abandoned treatment, simply because of unsatisfactory results without any adverse events. The other two patients received treatments at intervals of 3 months, which resulted in postinflammatory hyperpigmentation. Contrary to children, who generally show good response after two or three sessions of irradiation, we should consider more frequent irradiation, longer intervals between treatment sessions, and use of bleaching creams in the treatment of persistent sacral Mongolian spots in adults.

Entities:  

Mesh:

Year:  2012        PMID: 22565344     DOI: 10.1007/s10103-012-1113-4

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  11 in total

1.  A retrospective analysis of complications in the treatment of nevus of Ota with the Q-switched alexandrite and Q-switched Nd:YAG lasers.

Authors:  H H Chan; R S Leung; S Y Ying; C F Lai; T Kono; J K Chua; W S Ho
Journal:  Dermatol Surg       Date:  2000-11       Impact factor: 3.398

2.  Comparison of regional efficacy and complications in the treatment of aberrant Mongolian spots with the Q-switched ruby laser.

Authors:  Makiko Shirakawa; Toshiyuki Ozawa; Natsuko Ohasi; Masamitsu Ishii; Teruichi Harada
Journal:  J Cosmet Laser Ther       Date:  2010-06       Impact factor: 2.247

3.  Treatment of 153 Japanese patients with Q-switched alexandrite laser.

Authors:  Shinji Kagami; Akihiko Asahina; Rei Watanabe; Yoshihiro Mimura; Akira Shirai; Naoko Hattori; Takahiro Watanabe; Kunihiko Tamaki
Journal:  Lasers Med Sci       Date:  2007-01-16       Impact factor: 3.161

4.  Persistent Mongolian spot in the adult.

Authors:  A Hidano
Journal:  Arch Dermatol       Date:  1971-06

5.  A retrospective study looking at the long-term complications of Q-switched ruby laser in the treatment of nevus of Ota.

Authors:  T Kono; M Nozaki; H H Chan; Y Mikashima
Journal:  Lasers Surg Med       Date:  2001       Impact factor: 4.025

6.  Mongolian spots remaining in schoolchildren a statistical survey in Central Okinawa.

Authors:  I Kikuchi
Journal:  J Dermatol       Date:  1980-06       Impact factor: 4.005

7.  Natural history of the Mongolian spot.

Authors:  I Kikuchi; S Inoue
Journal:  J Dermatol       Date:  1980-12       Impact factor: 4.005

8.  A study of Q-switched Nd:YAG laser irradiation and paracrine function in human skin cells.

Authors:  Andrew Burd; Ningwen Zhu; Vincent K M Poon
Journal:  Photodermatol Photoimmunol Photomed       Date:  2005-06       Impact factor: 3.135

Review 9.  Postinflammatory hypopigmentation and hyperpigmentation.

Authors:  R Ruiz-Maldonado; M L Orozco-Covarrubias
Journal:  Semin Cutan Med Surg       Date:  1997-03

10.  Effect of cold air cooling on the incidence of postinflammatory hyperpigmentation after Q-switched Nd:YAG laser treatment of acquired bilateral nevus of Ota like macules.

Authors:  Woraphong Manuskiatti; Sasima Eimpunth; Rungsima Wanitphakdeedecha
Journal:  Arch Dermatol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.